| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/25/2002 | CA2433313A1 Polypetides and nucleic acids encoding same |
| 07/25/2002 | CA2430634A1 Proteins, polynucleotides encoding them and methods of using the same |
| 07/24/2002 | EP1225183A2 Human G-protein coupled receptor |
| 07/24/2002 | EP1224938A1 Gugulipid for treating cognitive disorders, hyperglycaemia and skin disorders |
| 07/24/2002 | EP1224936A1 Physical strength enhancing agents and glycogen accumulation promoting agents |
| 07/24/2002 | EP1224861A1 Animal with the mass expression of human gene and test method by using the animal |
| 07/24/2002 | EP1224322A2 Gene sequence variations with utility in determining the treatment of disease |
| 07/24/2002 | EP1224291A1 Multiple sclerosis-related superantigen |
| 07/24/2002 | EP1224283A2 Human and rat fgf-20 genes and gene expression products |
| 07/24/2002 | EP1224281A1 37 human secreted proteins |
| 07/24/2002 | EP1224220A2 Epo primary response gene 1, eprg1 |
| 07/24/2002 | EP1224209A1 10 human secreted proteins |
| 07/24/2002 | EP1224207A1 5-hydroxysapogenin derivatives with anti-dementia activity |
| 07/24/2002 | EP1224203A2 Antisense modulation of protein kinase c-theta expression |
| 07/24/2002 | EP1224202A1 Antisense modulation of integrin-linked kinase expression |
| 07/24/2002 | EP1224201A1 32 human secreted proteins |
| 07/24/2002 | EP1224200A1 Tissue plasminogen activator-like protease |
| 07/24/2002 | EP1224195A1 C-aryl glucoside sglt2 inhibitors |
| 07/24/2002 | EP1224187A2 Certain alkylene diamine-substituted heterocycles |
| 07/24/2002 | EP1224183A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 07/24/2002 | EP1224180A2 Substituted azoles |
| 07/24/2002 | EP1224179A2 Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/24/2002 | EP1224178A1 Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics |
| 07/24/2002 | EP1224175A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224174A2 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists |
| 07/24/2002 | EP1224173A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 07/24/2002 | EP1224160A1 Polymorphic forms of sertraline hydrochloride |
| 07/24/2002 | EP1224155A2 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 07/24/2002 | EP1224022A1 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 07/24/2002 | EP1223988A1 Antisense modulation of tumor necrosis factor alpha converting enzyme (tace) expression |
| 07/24/2002 | EP1223974A2 Medicament in order to induce tolerance |
| 07/24/2002 | EP1223966A2 Use of gdnf for treating corneal defects |
| 07/24/2002 | EP1223961A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 07/24/2002 | EP1223950A2 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 07/24/2002 | EP1223946A1 Human neuropeptide receptor |
| 07/24/2002 | EP1223939A1 Method of treating weight gain |
| 07/24/2002 | EP1223933A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 07/24/2002 | EP1223932A1 Compounds and methods |
| 07/24/2002 | EP1223929A1 Cannabimimetic indole derivatives |
| 07/24/2002 | EP1223927A2 Use of retigabin for treating neuropathic pain |
| 07/24/2002 | EP1223918A1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor |
| 07/24/2002 | EP1223915A1 Dry powder compositions having improved dispersivity |
| 07/24/2002 | EP1223913A2 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 07/24/2002 | EP1146896B1 Monodisperse hexameric acylated insulin analog formulations |
| 07/24/2002 | EP1056357B1 Calorically dense nutritional composition |
| 07/24/2002 | EP0946495B1 Phenyl acetamides as spla2 inhibitors |
| 07/24/2002 | EP0835263B9 Somatostatin peptides |
| 07/24/2002 | EP0739210B1 Compositions for local delivery of cytostatic agents |
| 07/24/2002 | EP0684945B1 Pyrazole- or isoxazole-substituted alkyl amide acat inhibitors |
| 07/24/2002 | CN1360596A Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 07/24/2002 | CN1360590A Androgen glycosides and androgenic activity thereof |
| 07/24/2002 | CN1360583A Novel compounds, their use and preparation |
| 07/24/2002 | CN1360582A Quinazoline derivs. |
| 07/24/2002 | CN1360581A Benzoylpyridazines |
| 07/24/2002 | CN1360574A Process for preparation of tricyclic amino alcohol derivs. |
| 07/24/2002 | CN1360499A Pharmaceutical composition contg. fenofibrate and preparation method |
| 07/24/2002 | CN1360493A Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/24/2002 | CN1359904A Potassium glycyrrhetate and its preparing process and use |
| 07/24/2002 | CN1359717A Process for prepairng Chinese-medicinal ointment of treating uremia, renal hypertension and hyperlipomia |
| 07/24/2002 | CN1359703A Oral liquid for detoxicating and dispelling wind |
| 07/24/2002 | CN1359699A Detoxicating and hypolipemic capsule |
| 07/24/2002 | CN1359693A Process for preparing dried soybean polypeptide powder with hypolipemic action |
| 07/24/2002 | CN1359692A Instant hypoglycemic medicine |
| 07/24/2002 | CN1359686A Zymolite of blue scad capable of improving function of brain cells and its preparing process |
| 07/24/2002 | CN1087951C Hypolipemic medicine for lossing weight and its preparing process |
| 07/24/2002 | CN1087946C Medicine for curing diabetes |
| 07/24/2002 | CN1087934C Use of phenalkylamines |
| 07/23/2002 | US6423754 Method for treating hypercholesterolemia with polyallylamine polymers |
| 07/23/2002 | US6423712 2,4-Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 07/23/2002 | US6423710 Cyclic AMP-specific phosphodiesterase inhibitors |
| 07/23/2002 | US6423700 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 07/23/2002 | CA2365997A1 Novel polypeptide |
| 07/23/2002 | CA2270195C Pharmaceutical composition for treatment of diabetes |
| 07/23/2002 | CA2097827C Enhanced bioavailability pharmaceutical composition containing probucol |
| 07/23/2002 | CA2060560C Method for insuring adequate intracellular glutathione in tissue |
| 07/23/2002 | CA2040865C Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor |
| 07/18/2002 | WO2002055705A2 Proteins and nucleic acids encoding same |
| 07/18/2002 | WO2002055698A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 07/18/2002 | WO2002055694A2 Discriminative nucleic acid analysis using clone sequence signatures |
| 07/18/2002 | WO2002055690A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/18/2002 | WO2002055671A1 Bacillus subtilis var. chungkookjang producing high molecular weight poly-gamma-glutamic acid |
| 07/18/2002 | WO2002055663A2 Srebp pathway modulation through targeting hisrs |
| 07/18/2002 | WO2002055556A2 Regulation of human voltage gated potassium channel protein kv2.2 |
| 07/18/2002 | WO2002055547A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 07/18/2002 | WO2002055541A2 Peptides having inhibiting activity on the production of nitric oxide |
| 07/18/2002 | WO2002055532A2 Variant growth hormone molecules conjugated with macromolecular compounds |
| 07/18/2002 | WO2002055525A1 Retinoid agonists |
| 07/18/2002 | WO2002055522A2 Novel multi-ring organic compounds for regulating gut motility and food intake |
| 07/18/2002 | WO2002055517A2 4-(hetero)aryl substituted indolinones |
| 07/18/2002 | WO2002055514A2 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 07/18/2002 | WO2002055510A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 07/18/2002 | WO2002055501A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/18/2002 | WO2002055498A1 Pharmaceutically active piperidine derivatives |
| 07/18/2002 | WO2002055497A1 Aryl piperidine derivatives as inducers of ldl-receptor expression |
| 07/18/2002 | WO2002055496A1 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression |
| 07/18/2002 | WO2002055495A1 Aryl piperidine derivatives as inducers of ldl-receptor expression |
| 07/18/2002 | WO2002055484A1 Biaryl compound, process for producing the same, and agent |
| 07/18/2002 | WO2002055481A1 Prodrugs of excitatory amino acids |
| 07/18/2002 | WO2002055152A2 Composition for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands |
| 07/18/2002 | WO2002055108A1 Targeted modification of intracellular compounds |